These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32679292)

  • 1. Trochlear Dysplasia Does Not Affect the Outcomes of Patellofemoral Autologous Chondrocyte Implantation.
    Barbieri Mestriner A; Ackermann J; Morlin Ambra LF; Franciozi CE; Faloppa F; Gomoll AH
    Arthroscopy; 2020 Dec; 36(12):3019-3027. PubMed ID: 32679292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes.
    Kraeutler MJ; Belk JW; Purcell JM; McCarty EC
    Am J Sports Med; 2018 Mar; 46(4):995-999. PubMed ID: 28423287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of "patellofemoral" cartilage lesions with matrix-assisted autologous chondrocyte transplantation: a comparison of patellar and trochlear lesions.
    Filardo G; Kon E; Andriolo L; Di Martino A; Zaffagnini S; Marcacci M
    Am J Sports Med; 2014 Mar; 42(3):626-34. PubMed ID: 24302700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Seeded Autologous Chondrocyte Implantation: A Simplified Implantation Technique That Maintains High Clinical Outcomes.
    Gomoll AH; Ambra LF; Phan A; Mastrocola M; Shah N
    Am J Sports Med; 2017 Apr; 45(5):1028-1036. PubMed ID: 28056183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial.
    Zeifang F; Oberle D; Nierhoff C; Richter W; Moradi B; Schmitt H
    Am J Sports Med; 2010 May; 38(5):924-33. PubMed ID: 19966102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation.
    Mestriner AB; Ackermann J; Merkely G; Galvão PHSAF; Ambra LFM; Gomoll AH
    Cartilage; 2021 Dec; 13(1_suppl):1298S-1305S. PubMed ID: 34286619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Chondrocytic Gene Expression Is Associated With Improved Repair Tissue Quality and Graft Survival in Patients After Autologous Chondrocyte Implantation.
    Ackermann J; Merkely G; Mestriner AB; Shah N; Gomoll AH
    Am J Sports Med; 2019 Oct; 47(12):2919-2926. PubMed ID: 31433670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is implantation of autologous chondrocytes superior to microfracture for articular-cartilage defects of the knee? A systematic review of 5-year follow-up data.
    Na Y; Shi Y; Liu W; Jia Y; Kong L; Zhang T; Han C; Ren Y
    Int J Surg; 2019 Aug; 68():56-62. PubMed ID: 31220632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Chondrocyte Implantation for Bipolar Chondral Lesions in the Patellofemoral Compartment: Clinical Outcomes at a Mean 9 Years' Follow-up.
    Ogura T; Bryant T; Merkely G; Minas T
    Am J Sports Med; 2019 Mar; 47(4):837-846. PubMed ID: 30758979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outcomes with combined autologous chondrocyte implantation and patellofemoral osteotomy versus isolated autologous chondrocyte implantation.
    Trinh TQ; Harris JD; Siston RA; Flanigan DC
    Arthroscopy; 2013 Mar; 29(3):566-74. PubMed ID: 23312875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-look assessment after all-arthroscopic autologous chondrocyte implantation with spheroides at the knee joint.
    Siebold R; Karidakis G; Feil S; Fernandez F
    Knee Surg Sports Traumatol Arthrosc; 2016 May; 24(5):1678-85. PubMed ID: 26704798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malalignment and cartilage lesions in the patellofemoral joint treated with autologous chondrocyte implantation.
    Vasiliadis HS; Lindahl A; Georgoulis AD; Peterson L
    Knee Surg Sports Traumatol Arthrosc; 2011 Mar; 19(3):452-7. PubMed ID: 20845030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee.
    Teo AQA; Wong KL; Shen L; Lim JY; Toh WS; Lee EH; Hui JHP
    Am J Sports Med; 2019 Oct; 47(12):2881-2887. PubMed ID: 31433674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes After Autologous Chondrocyte Implantation in Adolescents' Knees: A Systematic Review.
    DiBartola AC; Wright BM; Magnussen RA; Flanigan DC
    Arthroscopy; 2016 Sep; 32(9):1905-16. PubMed ID: 27161508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after first-generation autologous chondrocyte implantation for cartilage defects of the knee.
    Niemeyer P; Porichis S; Steinwachs M; Erggelet C; Kreuz PC; Schmal H; Uhl M; Ghanem N; Südkamp NP; Salzmann G
    Am J Sports Med; 2014 Jan; 42(1):150-7. PubMed ID: 24145948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaReS (MACT) versus microfracture in treating symptomatic patellofemoral cartilage defects: a retrospective matched-pair analysis.
    Petri M; Broese M; Simon A; Liodakis E; Ettinger M; Guenther D; Zeichen J; Krettek C; Jagodzinski M; Haasper C
    J Orthop Sci; 2013 Jan; 18(1):38-44. PubMed ID: 23001127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation.
    Ebert JR; Schneider A; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous chondrocyte implantation in the patella: a multicenter experience.
    Gomoll AH; Gillogly SD; Cole BJ; Farr J; Arnold R; Hussey K; Minas T
    Am J Sports Med; 2014 May; 42(5):1074-81. PubMed ID: 24595400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: prospective evaluation at average 4-year follow-up.
    Pascual-Garrido C; Slabaugh MA; L'Heureux DR; Friel NA; Cole BJ
    Am J Sports Med; 2009 Nov; 37 Suppl 1():33S-41S. PubMed ID: 19861699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical and radiologic evaluation of patellofemoral matrix-induced autologous chondrocyte implantation.
    Ebert JR; Fallon M; Smith A; Janes GC; Wood DJ
    Am J Sports Med; 2015 Jun; 43(6):1362-72. PubMed ID: 25784629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.